Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

167 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

NCT02410200

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site San Bernardino, California, United States
  • Research Site Ghent, Belgium
  • Research Site Sofia, Bulgaria
  • Research Site Hradec Králové, Czechia
View Trial Details
Completed

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

NCT00930553

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Barrow Neurology Clinics - Barrow Neurological Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona (Scottsdale) Scottsdale, Arizona, United States
View all 176 locations
View Trial Details
Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

NCT00548405

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Hope Research Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona, Department of Neurology Scottsdale, Arizona, United States
View all 191 locations
View Trial Details

Related conditions